XML 35 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Note 1 - Nature of the Business and Basis of Preparation - Schedule of Subsidiaries (Details)
Mar. 31, 2020
BeyondSpring Pharmaceuticals Inc. [Member]  
Equity method investment, ownership percentage 100.00%
BeyondSpring Ltd. [Member]  
Equity method investment, ownership percentage 100.00%
BeyondSpring HK [Member]  
Equity method investment, ownership percentage 100.00%
Wanchun Biotechnology Limited [Member]  
Equity method investment, ownership percentage 100.00%
Wanchun Biotechnology (Shenzhen) Ltd. [Member]  
Equity method investment, ownership percentage 100.00%
Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”) [Member]  
Equity method investment, ownership percentage 57.97%
BeyondSpring Pharmaceuticals Australia PTY Ltd. (“BeyondSpring Australia”) [Member]  
Equity method investment, ownership percentage 100.00%
Beijing Wanchun Pharmaceutical Technology Ltd. [Member]  
Equity method investment, ownership percentage 57.97%
SEED Therapuetics Inc. [Member]  
Equity method investment, ownership percentage 100.00%
SEED Technology Limited [Member]  
Equity method investment, ownership percentage 57.97%